| Heading: |
Prescription Drugs: Electronic Signatures |
| Question ID: |
1797275 |
| UIN: |
48245 |
| House: |
Commons |
| Date tabled: |
2025-04-25 |
| Asking Member ID: |
5138 |
| Asking Member display name: |
Ian Roome
|
| Asking Member handle: |
IanRoomeMP
|
| Asking Member Twitter reference: |
@IanRoomeMP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, with reference to the Home Office's letter to the Advisory Council on the Misuse of Drugs, dated 29 September 2023, what his Department's planned timetable is for the use of electronic signatures f |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-04-30 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is unable to confirm a timetable at this stage. Amendments to the Human Medicines Regulations 2012 and Misuse of Drug Regulations 2001 would be required to enable electronic prescribing in named settings, such as secondary care and the heal... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |